BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16864160)

  • 21. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Change of N-terminal pro-brain natriuretic peptide and big endothelin in patients undergoing coronary artery bypass grafting].
    Lu YF; Qi HW; Tang CZ; Wu MY; Wang Y; Zhao FH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):667-70. PubMed ID: 17996134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma catecholamines and N-terminal proBNP in patients with acute myocardial infarction undergoing primary angioplasty. Relation to left ventricular function and clinical outcome.
    Hartmann F; Kurowski V; Maghsoudi A; Kurz T; Schwarz M; Bonnemeier H; Tölg R; Jain D; Wiegand U; Katus H; Richardt G
    Z Kardiol; 2003 Jan; 92(1):73-81. PubMed ID: 12545304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
    Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease.
    Lalor SM; Connolly DJ; Elliott J; Syme HM
    J Vet Cardiol; 2009 May; 11 Suppl 1():S71-9. PubMed ID: 19398225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The plasma level of an inactive moiety of B-type natriuretic peptide precursor as a predictor of cardiac function during operations under extracorporeal circulation].
    Kozlov IA; Krichevskiĭ LA; Shumakov DV; Kharlamova IE; Ermakova IP; Nikonova TIu; Zavgorodniĭ VN
    Anesteziol Reanimatol; 2006; (3):30-3. PubMed ID: 16889209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
    Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C
    Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study.
    Morillas P; Castillo J; Quiles J; Nuñez D; Guillén S; Maceira A; Rivera M; Bertomeu V
    Rev Esp Cardiol; 2008 Sep; 61(9):972-5. PubMed ID: 18775240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL; Qiu YR; Zhou F; Feng PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
    Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
    Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
    Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain natriuretic peptide levels during cardiac reperfusion: comparison between percutaneous coronary angioplasty and aorto-coronaric bypass.
    Palazzuoli A; Carrera A; Calabria P; Pastore M; Quatrini I; Vecchiato L; Campagna MS; Palazzuoli V; Nuti R
    Clin Chim Acta; 2004 Apr; 342(1-2):87-92. PubMed ID: 15026268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
    Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
    J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.